In a previous study, using an antibody that recognizes both the reduced and oxidized forms of GSH, the strongest signal was observed in bacteroids in mature pea nodules
The FDA approved Foundayo (orforglipron) in April 2026 as the first oral GLP-1 weight loss medication that can be taken with food at any time of day
Glutathione level decreases during cold stress conditions and thus supplementation of GSH to the medium or native GSH synthesis by bacterial cells could replenish this loss and may help to cope up with such conditions
In addition, kidney weight was markedly reduced in GH-treated and untreated JAK2 -/- mice compared to controls, indicating the importance of circulating IGF-1 in kidney growth, whereas locally produced IGF-1 seems not to have a significant impact on kidney growth
The Triple Therapy program is intended for patients who do not meet the BMI requirements to start a GLP-1 program but still seek help managing their weight
Addressing glucose concerns is a huge part of the puzzle
